Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03583008 · ClinicalTrials.gov registry record · NA
Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT03583008: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT03583008 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03583008, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The SUPPORT-AF study aims to improve rates of anticoagulation (AC) in atrial fibrillation (AF) patients by developing and delivering supportive tools and educational materials to providers treating patients with AF. The investigators hypothesize that AC percentage will increase among providers receiving tools and educational content.
Primary Outcome
The first primary outcome measure is to determine the impact of the intervention on provider prescribing rates (increase, decrease, same)
Interventions
- BEHAVIORAL Anticoagulation (AC) Intervention--Academic Detailing
- BEHAVIORAL Anticoagulation (AC) Intervention--Prescribing Practices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2018-06-11 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
What the finished NCT03583008 record still lists
NCT03583008 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Anticoagulation (AC) Intervention--Academic Detailing is the first listed.
NCT03583008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03583008 about?
NCT03583008 is a clinical study titled "Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF". The SUPPORT-AF study aims to improve rates of anticoagulation (AC) in atrial fibrillation (AF) patients by developing and delivering supportive tools and educational materials to providers treating patients with AF. The investigators hypothesize that AC percentage will increase among providers recei...
What is the current status of trial NCT03583008?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2018-06-11. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT03583008?
The interventions under investigation include: Anticoagulation (AC) Intervention--Academic Detailing (BEHAVIORAL), Anticoagulation (AC) Intervention--Prescribing Practices (BEHAVIORAL).
Who is sponsoring clinical trial NCT03583008?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03583008's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI